Nature Biotechnology spotlights Taconic Biosciences' Dr. Adriano Flora because of his expertise with CRISPR-engineered models:
"CRISPR-Cas9 genome editing has rekindled interest in the rat as a model of human disease.
The US National Institutes of Health awarded The Jackson Laboratory $28.3 million in August to produce 1,000 lines of genetically modified mice.
The task, which would have seemed intractable a few short years ago[...]" Read the complete article at: Nature.com
"CRISPR-Cas9 genome editing has rekindled interest in the rat as a model of human disease. The US National Institutes of Health awarded The Jackson Laboratory $28.3 million in August to produce 1,000 lines of genetically modified mice.
The task, which would have seemed intractable a few short years ago[...]"